Senior Computational Drug Hunter
AqemiaLondon, England, United Kingdom • Paris, Ile-de-France, France
Posted July 31, 2025
Full Time
About the Company
Aqemia is a next-gen pharmatech company focused on drug discovery using quantum-inspired physics algorithms to power generative AI. The company designs innovative drug candidates for critical diseases like immuno-oncology without relying on experimental data, achieving several successes internally and through collaborations. Aqemia is part of the French Tech 120 program and has offices in Paris and London.
Job Description
AQEMIA is a next-gen pharmatech company advancing one of the world's fastest-growing drug discovery pipelines. As a Senior Computational Drug Hunter, you will play a strategic and hands-on role across multiple drug discovery projects.
Requirements
- PhD or equivalent experience in Computational Chemistry, Biophysics, Cheminformatics, or a related field.
- 5–10 years of experience in drug discovery, including at least 5 years in the drug discovery industry
- Proven track record in small molecule structure-based and ligand-based design, SAR interpretation, and hypothesis generation.
Benefits
- Expanding Drug Discovery Pipeline: Focused on critical therapeutic areas like Oncology, CNS, Immuno-inflammation - with in vivo proof of concept/patent stage programs.
- Elite Collaborations: Partnered with major pharmas, including a $140M+ collaboration with Sanofi.
- Tech + Bio Excellence: Be part of an interdisciplinary team combining the best of physics, AI, chemistry, and biology.
- Strong Growth & Support: Backed by over $100M in funding, and named a French Tech 120 company.
- Great Locations: Offices in central Paris and London (King’s Cross), with 2 remote days/week.
- Relocation & Integration: International environment with relocation support and French lessons offered (if needed)
